It was showed an increase on Translate Bio Inc (NASDAQ:TBIO)’s shorted shares with 4.24%. FINRA issued in April TBIO’s total 1.15 million shorted shares. Previously was reported up change of 4.24% from 1.11M shares. 13 days will cost TBIO with 88,500 average volume to recover its previous position. Translate Bio Inc float short is 7.19%.

The stock increased 4.54% or $0.53 during the last trading session, reaching $12.21.Translate Bio, Inc. has 200,744 shares volume, 1.73% up from normal. TBIO is and has moved 0.00% since April 4, 2018. The stock underperformed the S&P 500 by 4.37%.

Translate Bio, Inc., a messenger RNA therapeutics company, engages in developing medicines to treat diseases caused by protein or gene dysfunction.The company has $552.79 million market cap. It is developing MRT5005 that is in Phase I/II clinical trial for the treatment of cystic fibrosis; and MRT5201 for the treatment of ornithine transcarbamylase deficiency.Currently it has negative earnings. It has strategic alliances with Sanofi Pasteur.

Translate Bio, Inc. (NASDAQ:TBIO) Ratings Coverage

In total 2 analysts cover Translate Bio (NASDAQ:TBIO). “Buy” rating has 2, “Sell” are 0, while 0 are “Hold”. (NASDAQ:TBIO) has 100% bullish analysts. 3 are the (NASDAQ:TBIO)’s ratings reports on Apr 4, 2019 according to StockzIntelligence Inc. On Monday, March 25 H.C. Wainwright maintained Translate Bio, Inc. (NASDAQ:TBIO) rating. H.C. Wainwright has “Buy” rating and $21 target. In Wednesday, November 14 report Leerink Swann maintained the stock with “Outperform” rating.

For more Translate Bio, Inc. (NASDAQ:TBIO) news brought out briefly go to: Benzinga.com, Streetinsider.com, Benzinga.com, Globenewswire.com or Globenewswire.com. The titles are as follows: “50 Stocks Moving In Friday’s Mid-Day Session – Benzinga” brought out on March 08, 2019, “Translate Bio (TBIO) Announces Publication of Preclinical Data Demonstrating Efficacy of Systemic mRNA Delivery in Fabry Disease Model – StreetInsider.com” on March 18, 2019, “58 Biggest Movers From Yesterday – Benzinga” with a publish date: April 02, 2019, “Translate Bio to Participate in Upcoming Investor Conferences – GlobeNewswire” and the last “Translate Bio Appoints Pasquale (Pat) Sacco as Senior Vice President of Technical Operations – GlobeNewswire” with publication date: April 01, 2019.